Table of Contents

1 Liver-on-a-Chip Model Market Overview

• 1.1 Product Overview and Scope of Liver-on-a-Chip Model
• 1.2 Liver-on-a-Chip Model Segment by Type
  • 1.2.1 Global Liver-on-a-Chip Model Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Single-organ Systems
  • 1.2.3 Multi-organ Systems
• 1.3 Liver-on-a-Chip Model Segment by Application
  • 1.3.1 Global Liver-on-a-Chip Model Sales Comparison by Application: (2022-2028)
  • 1.3.2 Pharmaceutical and Biotechnology Companies
  • 1.3.3 Academic Research Institutes
• 1.4 Global Liver-on-a-Chip Model Market Size Estimates and Forecasts
  • 1.4.1 Global Liver-on-a-Chip Model Revenue 2017-2028
  • 1.4.2 Global Liver-on-a-Chip Model Sales 2017-2028
  • 1.4.3 Liver-on-a-Chip Model Market Size by Region: 2017 Versus 2021 Versus 2028

2 Liver-on-a-Chip Model Market Competition by Manufacturers

• 2.1 Global Liver-on-a-Chip Model Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Liver-on-a-Chip Model Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Liver-on-a-Chip Model Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Liver-on-a-Chip Model Manufacturing Sites, Area Served, Product Type
• 2.5 Liver-on-a-Chip Model Market Competitive Situation and Trends
  • 2.5.1 Liver-on-a-Chip Model Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Liver-on-a-Chip Model Players Market Share by Revenue
  • 2.5.3 Global Liver-on-a-Chip Model Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Liver-on-a-Chip Model Retrospective Market Scenario by Region

• 3.1 Global Liver-on-a-Chip Model Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Liver-on-a-Chip Model Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Liver-on-a-Chip Model Market Facts & Figures by Country
  • 3.3.1 North America Liver-on-a-Chip Model Sales by Country
  • 3.3.2 North America Liver-on-a-Chip Model Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Liver-on-a-Chip Model Market Facts & Figures by Country
  • 3.4.1 Europe Liver-on-a-Chip Model Sales by Country
  • 3.4.2 Europe Liver-on-a-Chip Model Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Liver-on-a-Chip Model Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Liver-on-a-Chip Model Sales by Region
  • 3.5.2 Asia Pacific Liver-on-a-Chip Model Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Liver-on-a-Chip Model Market Facts & Figures by Country
  • 3.6.1 Latin America Liver-on-a-Chip Model Sales by Country
  • 3.6.2 Latin America Liver-on-a-Chip Model Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Liver-on-a-Chip Model Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Liver-on-a-Chip Model Sales by Country
  • 3.7.2 Middle East and Africa Liver-on-a-Chip Model Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Liver-on-a-Chip Model Historic Market Analysis by Type

• 4.1 Global Liver-on-a-Chip Model Sales Market Share by Type (2017-2022)
• 4.2 Global Liver-on-a-Chip Model Revenue Market Share by Type (2017-2022)
• 4.3 Global Liver-on-a-Chip Model Price by Type (2017-2022)

5 Global Liver-on-a-Chip Model Historic Market Analysis by Application

• 5.1 Global Liver-on-a-Chip Model Sales Market Share by Application (2017-2022)
• 5.2 Global Liver-on-a-Chip Model Revenue Market Share by Application (2017-2022)
• 5.3 Global Liver-on-a-Chip Model Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Emulate
  • 6.1.1 Emulate Corporation Information
  • 6.1.2 Emulate Description and Business Overview
  • 6.1.3 Emulate Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Emulate Liver-on-a-Chip Model Product Portfolio
  • 6.1.5 Emulate Recent Developments/Updates
• 6.2 CN Bio Innovations
  • 6.2.1 CN Bio Innovations Corporation Information
  • 6.2.2 CN Bio Innovations Description and Business Overview
  • 6.2.3 CN Bio Innovations Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 CN Bio Innovations Liver-on-a-Chip Model Product Portfolio
  • 6.2.5 CN Bio Innovations Recent Developments/Updates
• 6.3 TissUse
  • 6.3.1 TissUse Corporation Information
  • 6.3.2 TissUse Description and Business Overview
  • 6.3.3 TissUse Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 TissUse Liver-on-a-Chip Model Product Portfolio
  • 6.3.5 TissUse Recent Developments/Updates
• 6.4 Hesperos
  • 6.4.1 Hesperos Corporation Information
  • 6.4.2 Hesperos Description and Business Overview
  • 6.4.3 Hesperos Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Hesperos Liver-on-a-Chip Model Product Portfolio
  • 6.4.5 Hesperos Recent Developments/Updates
• 6.5 Mimetas
  • 6.5.1 Mimetas Corporation Information
  • 6.5.2 Mimetas Description and Business Overview
  • 6.5.3 Mimetas Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Mimetas Liver-on-a-Chip Model Product Portfolio
  • 6.5.5 Mimetas Recent Developments/Updates
• 6.6 Micronit Microtechnologies B.V.
  • 6.6.1 Micronit Microtechnologies B.V. Corporation Information
  • 6.6.2 Micronit Microtechnologies B.V. Description and Business Overview
  • 6.6.3 Micronit Microtechnologies B.V. Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Micronit Microtechnologies B.V. Liver-on-a-Chip Model Product Portfolio
  • 6.6.5 Micronit Microtechnologies B.V. Recent Developments/Updates
• 6.7 Kirkstall
  • 6.6.1 Kirkstall Corporation Information
  • 6.6.2 Kirkstall Description and Business Overview
  • 6.6.3 Kirkstall Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Kirkstall Liver-on-a-Chip Model Product Portfolio
  • 6.7.5 Kirkstall Recent Developments/Updates
• 6.8 Cherry Biotech SAS
  • 6.8.1 Cherry Biotech SAS Corporation Information
  • 6.8.2 Cherry Biotech SAS Description and Business Overview
  • 6.8.3 Cherry Biotech SAS Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Cherry Biotech SAS Liver-on-a-Chip Model Product Portfolio
  • 6.8.5 Cherry Biotech SAS Recent Developments/Updates
• 6.9 Revivocell
  • 6.9.1 Revivocell Corporation Information
  • 6.9.2 Revivocell Description and Business Overview
  • 6.9.3 Revivocell Liver-on-a-Chip Model Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Revivocell Liver-on-a-Chip Model Product Portfolio
  • 6.9.5 Revivocell Recent Developments/Updates

7 Liver-on-a-Chip Model Manufacturing Cost Analysis

• 7.1 Liver-on-a-Chip Model Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Liver-on-a-Chip Model
• 7.4 Liver-on-a-Chip Model Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Liver-on-a-Chip Model Distributors List
• 8.3 Liver-on-a-Chip Model Customers

9 Liver-on-a-Chip Model Market Dynamics

• 9.1 Liver-on-a-Chip Model Industry Trends
• 9.2 Liver-on-a-Chip Model Market Drivers
• 9.3 Liver-on-a-Chip Model Market Challenges
• 9.4 Liver-on-a-Chip Model Market Restraints

10 Global Market Forecast

• 10.1 Liver-on-a-Chip Model Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Liver-on-a-Chip Model by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Liver-on-a-Chip Model by Type (2023-2028)
• 10.2 Liver-on-a-Chip Model Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Liver-on-a-Chip Model by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Liver-on-a-Chip Model by Application (2023-2028)
• 10.3 Liver-on-a-Chip Model Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Liver-on-a-Chip Model by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Liver-on-a-Chip Model by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

Summary:

Liver-on-a-Chip Model is to study toxicity mechanisms of preclinical drug candidates to help reduce clinical trial safety failures.
Industry Insights
Due to the COVID-19 pandemic, the global Liver-on-a-Chip Model market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Liver-on-a-Chip Model market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Liver-on-a-Chip Model landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Single-organ Systems accounting for % of the Liver-on-a-Chip Model global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical and Biotechnology Companies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Liver-on-a-Chip Model include Emulate, CN Bio Innovations, TissUse, Hesperos, Mimetas, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS and Revivocell. etc. In terms of revenue, the global 3 largest players have a % market share of Liver-on-a-Chip Model in 2021.
This report focuses on Liver-on-a-Chip Model volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Liver-on-a-Chip Model market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Liver-on-a-Chip Model market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Single-organ Systems
Multi-organ Systems
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Emulate
CN Bio Innovations
TissUse
Hesperos
Mimetas
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Revivocell
Frequently Asked Questions
Which product segment grabbed the largest share in the Liver-on-a-Chip Model market?
How is the competitive scenario of the Liver-on-a-Chip Model market?
Which are the key factors aiding the Liver-on-a-Chip Model market growth?
Which are the prominent players in the Liver-on-a-Chip Model market?
Which region holds the maximum share in the Liver-on-a-Chip Model market?
What will be the CAGR of the Liver-on-a-Chip Model market during the forecast period?
Which application segment emerged as the leading segment in the Liver-on-a-Chip Model market?
What key trends are likely to emerge in the Liver-on-a-Chip Model market in the coming years?
What will be the Liver-on-a-Chip Model market size by 2028?
Which company held the largest share in the Liver-on-a-Chip Model market?